EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery-Reference-Cited by-同舟云学术

EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery

Published:2011-05 Issue:5 Volume:6 Page:947-950
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Helland Åslaug,Skaug Hege Marian,Kleinberg Lilach,Iversen Marius Lund,Rud Ane Kongsgaard,Fleischer Thomas,Sagerup Camilla,Solberg Steinar,Jørgensen Lars,Ariansen Sarah,Brustugun Odd Terje

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference9 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

3. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci USA,2004

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

5. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data on EGFR and ALK Testing and TKI Usage in Norway—A Nation-Wide Population Study;Cancers;2023-02-27

2. Factors affecting outcome in resected EGFR-mutated lung cancer;Acta Oncologica;2022-04-27

3. “How Long Have I Got?” in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question;Frontiers in Oncology;2021-12-21

4. Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients;Frontiers in Oncology;2020-11-25

5. Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study);Lung Cancer;2020-05